Biopendium is already being used by a number of major pharmaceutical and biotechnology companies such as Pfizer, Aventis, Daiichi, Genentech, Serono, Riken and UCB Pharma and is an important component of Inpharmatica's chemogenomics discovery platform, PharmaCarta.